LLY

Eli Lilly and Company (LLY) ESG Analysis Analysis (2026)

Invetso Score: 8.1/10 — Strong · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 8.4 (Strong)

LLY’s high R&D intensity supports a lower-carbon, science-led operating model versus peers that rely more on manufacturing scale and heavier physical footprints.

The company’s capital allocation toward research rather than asset-heavy expansion reduces environmental intensity relative to peers with larger plant and logistics exposure.

No major environmental controversy is provided in the supplied data, so the main ESG advantage remains structural process efficiency rather than disclosed emissions leadership.

Peer-relative environmental positioning is strong, but it is not clearly top-tier because the available evidence does not show best-in-class climate or resource targets.

Social

Score:

LLY’s elevated R&D spend indicates sustained investment in medicines and patient outcomes, which is a stronger social signal than peers with lower innovation intensity.

Low stock-based compensation relative to revenue suggests less dilution pressure and a more restrained pay structure than many large-cap peers, supporting workforce alignment.

The company’s social profile is likely supported by the public-health nature of its products, although the provided data do not evidence superior access or affordability practices.

Peer-relative social positioning is strong, but the absence of disclosed metrics on access, pricing, and supply-chain labor limits confidence in a higher score.

Governance

Score:

LLY’s stock-based compensation to revenue is low, which generally indicates tighter governance discipline than peers that use heavier equity pay.

Moderate leverage, with debt-to-equity and net debt-to-EBITDA at manageable levels, suggests balance-sheet governance is not materially weaker than peer norms.

High gross margin can support governance flexibility, but it also increases scrutiny around pricing practices and stakeholder oversight relative to peers.

The available data point to solid governance discipline, yet the lack of filing-based detail on board independence, controls, and controversies prevents a top-tier assessment.

Overall Score

Score:

LLY screens as a strong ESG name versus peers, led by R&D-driven social and environmental efficiency with generally disciplined governance.

Score Driver: High R&D Intensity Relative To Revenue, Which Supports Both Environmental Efficiency And Social Value Creation Versus Peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Eli Lilly and Company. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →